Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -567,53 | 48,85k | Verkauf | 86,08 | 2,48k | -18,63% |
| 2026-05-27 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -23,15k | 2,00M | Verkauf | 86,42 | 133,29k | -14,80% |
| 2026-05-22 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -1,50k | 126,91k | Verkauf | 84,60 | 19,43k | -7,17% |
| 2026-05-18 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -620,00 | 5,25k | Derivative Exercise and Sale | 72,68 - 81,14 | 12,79k | - |
| 2026-05-15 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -17,97k | 1,47M | Verkauf | 81,82 - 82,07 | 156,44k | -10,30% |
| 2026-05-11 | Mr. Bernard J. ZovighianCEO & Director | -47,21k | 2,09M | Derivative Exercise and Sale | 79,96 | 114,94k | - |
| 2026-05-12 | Mr. Bernard J. ZovighianCEO & Director | -36,35k | 2,83M | Automatic Disposition | 77,92 - 78,40 | 114,94k | -24,03% |
| 2026-05-12 | Mr. Bernard J. ZovighianCEO & Director | -5,63k | 0,00 | Other Disposition | - | 114,94k | -4,67% |
| 2026-05-11 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -7,47k | 597,22k | Derivative Exercise and Sale | 79,96 | 174,40k | - |
| 2026-05-11 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | 5,99k | 0,00 | Derivative Exercise and Retained Stock | - | 174,40k | 3,56% |
| 2026-05-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -7,54k | 602,74k | Derivative Exercise and Sale | 79,96 | 20,93k | - |
| 2026-05-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | 6,05k | 0,00 | Derivative Exercise and Retained Stock | - | 20,93k | 40,63% |
| 2026-05-11 | Mr. Scott B. UllemInsider | -11,00k | 879,88k | Derivative Exercise and Sale | 79,96 | 294,62k | - |
| 2026-05-11 | Mr. Scott B. UllemInsider | 8,83k | 0,00 | Derivative Exercise and Retained Stock | - | 294,62k | 3,09% |
| 2026-05-07 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -490,00 | 40,67k | Sale to Issuer | 82,76 - 83,20 | 2,25k | -17,88% |
| 2026-05-11 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -593,00 | 47,28k | Verkauf | 79,73 | 2,25k | -20,85% |
| 2026-05-07 | Mr. Bernard J. ZovighianCEO & Director | -9,55k | 792,27k | Sale to Issuer | 82,76 - 83,20 | 130,28k | -6,83% |
| 2026-05-08 | Mr. Bernard J. ZovighianCEO & Director | -9,71k | 0,00 | Other Disposition | - | 130,28k | -6,94% |
| 2026-05-11 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -362,00 | 28,95k | Sale to Issuer | 79,96 | 12,79k | -2,75% |
| 2026-05-07 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -1,87k | 155,04k | Sale to Issuer | 82,76 - 83,20 | 166,81k | -1,11% |
| 2026-05-07 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -759,00 | 62,95k | Sale to Issuer | 82,76 - 83,20 | 13,15k | -5,46% |
| 2026-05-08 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -289,00 | 23,92k | Sale to Issuer | 82,76 | 3,05k | -8,67% |
| 2026-05-07 | Mr. Scott B. UllemInsider | -3,03k | 251,70k | Sale to Issuer | 82,76 - 83,20 | 283,43k | -1,06% |
| 2026-05-07 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -1,82k | 150,51k | Sale to Issuer | 82,76 - 83,20 | 13,26k | -12,04% |
| 2026-05-08 | Ms. Annette Maria BrulsCorp. VP of EMEA, Canada, & Latin America | -84,00 | 6,95k | Sale to Issuer | 82,76 | 3,38k | -2,43% |
| 2026-05-05 | Mr. Scott B. UllemInsider | 1,87k | 110,75k | Derivative Exercise and Retained Stock | 59,26 | 280,35k | 0,67% |
| 2026-05-05 | Mr. Scott B. UllemInsider | -11,13k | 263,28k | Derivative Exercise and Sale | 59,26 - 82,91 | 280,35k | - |
| 2026-05-03 | Mr. Scott B. UllemInsider | -620,00 | 52,07k | Sale to Issuer | 83,98 | 280,35k | -0,22% |
| 2026-05-03 | Mr. Bernard J. ZovighianCEO & Director | -515,00 | 43,25k | Sale to Issuer | 83,98 | 96,03k | -0,53% |
| 2026-05-05 | Mr. Bernard J. ZovighianCEO & Director | -523,00 | 0,00 | Other Disposition | - | 96,03k | -0,54% |
| 2026-05-01 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -2,04k | 49,40k | Derivative Exercise and Sale | 59,26 - 83,99 | 10,97k | - |
| 2026-05-03 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -252,00 | 21,16k | Sale to Issuer | 83,98 | 10,97k | -2,25% |
| 2026-05-03 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -469,00 | 39,39k | Sale to Issuer | 83,98 | 181,52k | -0,26% |
| 2026-05-03 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -282,00 | 23,68k | Sale to Issuer | 83,98 | 11,03k | -2,49% |
| 2026-04-09 | Mr. Scott B. UllemInsider | -13,00k | 270,21k | Derivative Exercise and Sale | 59,26 - 80,50 | 277,85k | - |
| 2026-04-06 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1,02k | 22,14k | Derivative Exercise and Sale | 59,26 - 80,98 | 11,22k | - |
| 2026-04-02 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -22,68k | 474,11k | Derivative Exercise and Sale | 59,26 - 80,59 | 181,96k | - |
| 2026-03-11 | Mr. Scott B. UllemInsider | -13,00k | 333,56k | Derivative Exercise and Sale | 59,26 - 85,21 | 277,85k | - |
| 2026-03-11 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1,02k | 26,62k | Derivative Exercise and Sale | 59,26 - 85,38 | 11,22k | - |
| 2026-03-02 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11,34k | 302,46k | Derivative Exercise and Sale | 59,26 - 85,93 | 181,92k | - |
| 2026-02-25 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -24,00k | 2,01M | Verkauf | 83,84 | 164,37k | -12,74% |
| 2026-02-22 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -432,00 | 34,46k | Sale to Issuer | 79,78 | 11,22k | -3,71% |
| 2026-02-22 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -176,00 | 14,04k | Sale to Issuer | 79,78 | 2,40k | -6,82% |
| 2026-02-16 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -456,00 | 34,60k | Sale to Issuer | 75,87 | 11,65k | -3,77% |
| 2026-02-16 | Mr. Scott B. UllemInsider | -199,00 | 15,10k | Sale to Issuer | 75,87 | 277,85k | -0,07% |
| 2026-02-12 | Mr. Bernard J. ZovighianCEO & Director | -25,35k | 217,58k | Derivative Exercise and Sale | 59,26 - 77,13 | 96,15k | - |
| 2026-01-09 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1,02k | 26,95k | Derivative Exercise and Sale | 59,26 - 85,70 | 12,15k | - |
| 2026-01-06 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11,34k | 299,46k | Derivative Exercise and Sale | 59,26 - 85,98 | 188,28k | - |
| 2025-12-12 | Ms. Leslie Stone HeiszIndependent Director | -2,62k | 218,12k | Verkauf | 83,41 | 27,42k | -8,71% |
| 2025-12-12 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11,39k | 953,75k | Verkauf | 83,74 - 83,79 | 188,28k | -5,70% |
| 2025-12-12 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -7,10k | 0,00 | Other Disposition | - | 188,28k | -3,63% |
| 2025-12-12 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1,02k | 25,24k | Derivative Exercise and Sale | 59,26 - 84,03 | 12,11k | - |
| 2025-12-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -2,00k | 168,75k | Verkauf | 84,38 | 10,50k | -16,01% |
| 2025-12-08 | Mr. Bernard J. ZovighianCEO & Director | -25,35k | 328,85k | Derivative Exercise and Sale | 59,26 - 85,21 | 93,18k | - |
| 2025-12-10 | Mr. Bernard J. ZovighianCEO & Director | -3,86k | 322,37k | Automatic Disposition | 83,45 | 93,18k | -3,98% |
| 2025-12-10 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11,34k | 278,61k | Derivative Exercise and Sale | 59,26 - 83,83 | 206,77k | - |
| 2025-12-09 | Mr. Scott B. UllemInsider | -7,70k | 194,14k | Derivative Exercise and Sale | 59,26 - 84,47 | 277,56k | - |
| 2025-12-08 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -583,00 | 50,14k | Verkauf | 86,01 | 1,66k | -26,00% |
| 2025-11-10 | Mr. Scott B. UllemInsider | -13,00k | 309,76k | Derivative Exercise and Sale | 59,26 - 83,30 | 277,56k | - |
| 2025-11-10 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1,02k | 23,75k | Derivative Exercise and Sale | 59,26 - 82,55 | 12,11k | - |
| 2025-09-13 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -262,00 | 20,32k | Sale to Issuer | 77,57 | 2,40k | -9,83% |
| 2025-09-14 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -650,00 | 50,42k | Sale to Issuer | 77,57 | 2,24k | -22,48% |
| 2025-08-25 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -2,50k | 204,87k | Verkauf | 81,95 | 12,50k | -16,67% |
| 2025-08-18 | Mr. Larry L. WoodInsider | -8,95k | 168,33k | Derivative Exercise and Sale | 59,26 - 78,06 | 182,84k | - |
| 2025-07-28 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -4,11k | 326,90k | Verkauf | 79,46 | 12,11k | -25,36% |
| 2025-07-11 | Ms. Annette Maria BrulsCorp. VP of EMEA, Canada, & Latin America | -109,00 | 8,59k | Sale to Issuer | 78,80 | 3,43k | -3,08% |
| 2025-07-07 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -333,00 | 25,57k | Sale to Issuer | 76,79 | 16,22k | -2,01% |
| 2025-06-16 | Mr. Larry L. WoodInsider | -8,95k | 142,92k | Derivative Exercise and Sale | 59,26 - 75,23 | 182,84k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
